Medulloblastoma, Group 3
Oncology·MeSH: Pyloric Stenosis, Hypertrophic
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Medulloblastoma, Group 3?
There are 1 clinical trial targeting Medulloblastoma, Group 3 tracked by BioSniper.
What is the prevalence of Medulloblastoma, Group 3?
The estimated prevalence of Medulloblastoma, Group 3 is approximately 5.0 per 100,000 population.
Deep-dive into Medulloblastoma, Group 3
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis